
Our client is an attractive, well-funded and fast growing clinical-stage biotech company building a robust and differentiated pipeline of “first-in-class” precision cardiovascular therapies and redefining/ modernizing the approach to cardiovascular drug development.
As the company is entering an exciting pivotal phase of clinical advancement, portfolio expansion and organizational growth, they are seeking an accomplished physician executive to lead/shape clinical strategy and direction of its highest-priority cardiovascular program while partnering directly with the CEO, CMO, executive leadership to influence corporate strategy, portfolio decisions, and the evolution of a world-class clinical development organization. This is a unique opportunity to assume significant strategic and operational ownership of a major cardiovascular asset, drive critical development decisions, and play an influential role in advancing a potentially transformative therapy toward regulatory approval.
You will play a central role in shaping both the program/portfolio strategy and the long-term direction of the organization. This is a rare combination of meaningful program ownership, executive visibility, exceptional science, and a chance to influence portfolio and company strategy, as well as building out a high-performing clinical development organization within one of the industry’s fastest growing biotech companies.
For an accomplished cardiovascular physician leader seeking greater ownership, broader strategic influence, and the opportunity to help shape an emerging leader in cardiovascular medicine, this represents a very unique and compelling career opportunity.
ATTRACTIVE FEATURES ABOUT THIS COMPANY & OPPORTUNITY:
RESPONSIBILITIES IN A NUTSHELL:
DESIRED EXPERIENCE:
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.